Skip to Content

CNN – Health

Women, older adults and those with lower income are more likely to use sleep medication, survey finds, despite potential health harms

By Janelle Chavez, CNN Millions of Americans say they regularly turn to medications for help falling or staying asleep, a practice that experts say can be dangerous for their health. A new study found that roughly 8% of US adults reported taking sleep medication every day or most days, with use more common among those

Continue Reading
Although fewer US adults are smoking cigarettes than ever

US tobacco control in 2022 gets a mixed review from the American Lung Association

By Jen Christensen, CNN Although fewer US adults are smoking cigarettes than ever, smoking remains the cause of the most preventable disability and death, and the nation’s smoking regulations are getting mixed grades from the American Lung Association. The association’s annual State of Tobacco Control report, published Wednesday, gives the federal government an A grade

Continue Reading
The US Centers for Disease Control and Prevention is ironing out the "logistical and legal" aspects of testing wastewater from airplanes for coronavirus variants as it continues to explore such a Covid-19 monitoring program.

CDC figuring out ‘logistical and legal’ aspects of testing airplane wastewater for coronavirus variants, source says

By Jacqueline Howard, CNN The US Centers for Disease Control and Prevention is ironing out the “logistical and legal” aspects of testing wastewater from airplanes for coronavirus variants as it continues to explore such an infectious disease monitoring program. The agency is still “figuring out how to operationalize this program,” a person close to CDC

Continue Reading
FDA has declined to grant accelerated approval to an experimental Alzheimer's drug

FDA declines to grant accelerated approval for Eli Lilly’s experimental Alzheimer’s treatment

By John Bonifield and Jacqueline Howard, CNN The US Food and Drug Administration declined to grant accelerated approval to an experimental Alzheimer’s drug, donanemab, and requested additional data from Eli Lilly and Company, the drug maker. The company, which announced the development on Thursday, plans to file Phase 3 clinical trial data later this year

Continue Reading
Skip to content